POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...
After years of stagnation in the search for a cure for Alzheimer’s — or at least breakthroughs — 2024 brought several exciting findings and confirmed others regarding the devastating dementing disease ...
These biomarkers not only aid in early diagnosis but also hold potential for predicting disease progression and response to treatment (58). 5.2 New biomarkers in Alzheimer’s disease: p-Tau181 and NfL ...
If there is an ongoing neurodegenerative disease ... play an important role in the maintenance of cognitive function and dementia risk. For instance, in my work with Ohio Senior Olympians over ...
While nearly 7 million Americans aged 65 and older suffer from Alzheimer's disease, experts are reflecting on the advances in diagnosis, treatment and risk management that have been made in 2024.
In other words, sleeping pills may help some people get some shut-eye but using them as a preventative treatment to ward off Alzheimer's disease is still a hazy prospect that hangs on a now-shaky ...
This extends beyond dementia and Alzheimer’s disease. Several neurological conditions, including multiple sclerosis, have been linked with infections or changes in the collection of microbes inside ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer's disease, the road to a cure seems long and uncertain. But as the year comes to a close, experts are ...
“While there is currently no cure for dementia, no cure does not mean no hope,” said Prof McCarron. “There is so much we can do to support the person to live well with dementia, and these dementia ...